Vivani Net Income from 2010 to 2026

VANI Stock  USD 1.26  0.03  2.33%   
Vivani Medical's Net Loss is decreasing with stable movements from year to year. Net Loss is predicted to flatten to about -28.4 M. For the period between 2010 and 2026, Vivani Medical, Net Loss quarterly trend regression had median of (23,486,000) and r-value of (0.12). View All Fundamentals
 
Net Loss  
First Reported
2013-03-31
Previous Quarter
-7.1 M
Current Value
-6.5 M
Quarterly Volatility
2.5 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Vivani Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vivani Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 408.7 K, Interest Expense of 8.9 M or Selling General Administrative of 7.9 M, as well as many indicators such as Price To Sales Ratio of 89.89, Dividend Yield of 0.0 or PTB Ratio of 3.42. Vivani financial statements analysis is a perfect complement when working with Vivani Medical Valuation or Volatility modules.
  
Build AI portfolio with Vivani Stock
Check out the analysis of Vivani Medical Correlation against competitors.
For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.
The Net Income trend for Vivani Medical offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Vivani Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Vivani Medical's Net Income Growth Pattern

Below is the plot of the Net Income of Vivani Medical over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Vivani Medical financial statement analysis. It represents the amount of money remaining after all of Vivani Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Vivani Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vivani Medical's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (23.49 M)10 Years Trend
Pretty Stable
   Net Income   
       Timeline  

Vivani Net Income Regression Statistics

Arithmetic Mean(23,403,165)
Coefficient Of Variation(35.60)
Mean Deviation6,995,295
Median(23,486,000)
Standard Deviation8,332,674
Sample Variance69.4T
Range25.9M
R-Value(0.12)
Mean Square Error73.1T
R-Squared0.01
Significance0.66
Slope(192,889)
Total Sum of Squares1110.9T

Vivani Net Income History

2026-28.4 M
2025-27 M
2024-23.5 M
2023-25.7 M
2022-13.9 M
2021-12.8 M
2020-9.3 M

Other Fundumenentals of Vivani Medical

About Vivani Medical Financial Statements

Investors use fundamental indicators, such as Vivani Medical's Net Income, to determine how well the company is positioned to perform in the future. Although Vivani Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Loss-27 M-28.4 M
Net Loss-21.1 M-22.2 M
Net Loss-10.3 M-10.8 M
Net Loss(0.38)(0.40)

Currently Active Assets on Macroaxis

When determining whether Vivani Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vivani Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vivani Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vivani Medical Stock:
Check out the analysis of Vivani Medical Correlation against competitors.
For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is there potential for Biotechnology market expansion? Will Vivani introduce new products? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.45)
Return On Assets
(0.50)
Return On Equity
(2.65)
Understanding Vivani Medical requires distinguishing between market price and book value, where the latter reflects Vivani's accounting equity. The concept of intrinsic value - what Vivani Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Vivani Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Vivani Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.